{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:29:07Z","timestamp":1784903347691,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"am","delay-in-days":384,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.rbmo.2021.06.007","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T19:46:14Z","timestamp":1623872774000},"page":"495-502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["IVF impact on the risk of recurrence of endometrial adenocarcinoma after fertility-sparing management"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4444-3009","authenticated-orcid":false,"given":"Ma\u00eflys","family":"Vaugon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00ebliss","family":"Peign\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Phelippeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mentine","family":"Gonthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Koskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.rbmo.2021.06.007_bib0001","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/humupd\/dmu012","article-title":"Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"20","author":"Barry","year":"2014","journal-title":"Hum. Reprod. Update"},{"issue":"1","key":"10.1016\/j.rbmo.2021.06.007_bib0002","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijgo.2015.06.046","article-title":"Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer","volume":"132","author":"Chen","year":"2016","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"6","key":"10.1016\/j.rbmo.2021.06.007_bib0003","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.fertnstert.2007.01.058","article-title":"Outcome of in vitro fertilization treatment in infertile women conservatively treated for endometrial adenocarcinoma","volume":"88","author":"Elizur","year":"2007","journal-title":"Fertility and Sterility"},{"issue":"9","key":"10.1016\/j.rbmo.2021.06.007_bib0004","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s10815-014-0297-x","article-title":"The outcome of infertility treatment in patients undergoing assisted reproductive technology after conservative therapy for endometrial cancer","volume":"31","author":"Fujimoto","year":"2014","journal-title":"J. Assist. Reprod. Genet."},{"issue":"4","key":"10.1016\/j.rbmo.2021.06.007_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.08.011","article-title":"Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis","volume":"207","author":"Gallos","year":"2012","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"1","key":"10.1016\/j.rbmo.2021.06.007_bib0006","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ygyno.2013.11.007","article-title":"Impact of obesity on the results of fertility-sparing management for atypical hyperplasia and grade 1 endometrial cancer","volume":"133","author":"Gonthier","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.rbmo.2021.06.007_bib0007","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/IGC.0b013e3181aae1fb","article-title":"Conservative treatment with progestin and pregnancy outcomes in endometrial cancer","volume":"19","author":"Hahn","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.rbmo.2021.06.007_bib0008","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/IGC.0b013e31827c18a1","article-title":"The influence of infertility treatment on the prognosis of endometrial cancer and atypical complex endometrial hyperplasia","volume":"23","author":"Ichinose","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.rbmo.2021.06.007_bib0009","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12958-015-0136-7","article-title":"Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia","volume":"14","author":"Inoue","year":"2016","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"4","key":"10.1016\/j.rbmo.2021.06.007_bib0010","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00404-019-05237-2","article-title":"Outcomes of in vitro fertilization cycles following fertility-sparing treatment in stage IA endometrial cancer","volume":"300","author":"Kim","year":"2019","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"3","key":"10.1016\/j.rbmo.2021.06.007_bib0011","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.fertnstert.2013.11.028","article-title":"Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis","volume":"101","author":"Koskas","year":"2014","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1016\/j.rbmo.2021.06.007_bib0012","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ogc.2018.09.006","article-title":"Endometrial Cancer: Obesity, Genetics, and Targeted Agents","volume":"46","author":"McDonald","year":"2019","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"issue":"1","key":"10.1016\/j.rbmo.2021.06.007_bib0013","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.fertnstert.2008.09.058","article-title":"Predictive factors for pregnancy after intrauterine insemination (IUI): An analysis of 1038 cycles and a review of the literature","volume":"93","author":"Merviel","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"35","key":"10.1016\/j.rbmo.2021.06.007_bib0014","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1200\/JCO.2016.69.4638","article-title":"Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment","volume":"34","author":"Onstad","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.rbmo.2021.06.007_bib0015","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/AOG.0b013e31827a0643","article-title":"Pregnancy Outcomes After Fertility-Sparing Management in Young Women With Early Endometrial Cancer","volume":"121","author":"Park","year":"2013","journal-title":"Obstetrics & Gynecology."},{"issue":"4","key":"10.1016\/j.rbmo.2021.06.007_bib0016","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ejca.2012.09.017","article-title":"Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer","volume":"49","author":"Park","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.rbmo.2021.06.007_bib0017","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.rbmo.2021.06.007_bib0018","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0015-0282(16)57652-3","article-title":"Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle","volume":"64","author":"Van Santbrink","year":"1995","journal-title":"Fertility and Sterility"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648321002911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648321002911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:21:45Z","timestamp":1761466905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648321002911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1472648321002911"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2021.06.007","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IVF impact on the risk of recurrence of endometrial adenocarcinoma after fertility-sparing management","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2021.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}